Bnp Paribas Asset Management Holding S.A. Syndax Pharmaceuticals Inc Transaction History
Bnp Paribas Asset Management Holding S.A.
- $38.6 Billion
- Q3 2025
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 1,236,077 shares of SNDX stock, worth $21.9 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,236,077
Previous 1,445,440
14.48%
Holding current value
$21.9 Million
Previous $13.5 Million
40.49%
% of portfolio
0.05%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding SNDX
# of Institutions
255Shares Held
101MCall Options Held
1.22MPut Options Held
1.24M-
Kynam Capital Management, LP Princeton, NJ8.52MShares$151 Million9.53% of portfolio
-
Black Rock Inc. New York, NY7.91MShares$140 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY5.8MShares$103 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.14MShares$91.1 Million0.0% of portfolio
-
Eversept Partners, LP New York, NY4.07MShares$72.1 Million3.84% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $1B
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...